MIRA INFORM REPORT

 

 

Report Date :

18.07.2014

 

IDENTIFICATION DETAILS

 

Name :

CHANDRA BHAGAT PHARMA PRIVATE LIMITED

 

 

Registered Office :

323-F, Bhagat Bhuvan, Dr. Ambedkar Road, Matunga (East), Mumbai – 400019, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

10.03.2003

 

 

Com. Reg. No.:

11-139534

 

 

Capital Investment / Paid-up Capital :

Rs. 2.500 Millions

 

 

CIN No.:

[Company Identification No.]

U24230MH2003PTC139534

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMC11692C

 

 

PAN No.:

[Permanent Account No.]

AACCC1056D

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Merchant Exporter of Pharmaceutical Formulations.

 

 

No. of Employees :

75 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (30)

 

RATING

STATUS

 

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having moderate track record.

 

The ratings reflect CBPPL’s modest scale of operations in the competitive pharmaceutical formulation space and stretched liquidity position of the company.

 

However, trade relations are fair. Business is active. Payment terms are slow but correct.

 

The company can be considered for business dealings with some caution.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

INDIAN ECONOMIC OVERVIEW

 

N E W S

 

The economy grew 4.7 %in 2013/14, marking a second straight year of sub-5 % growth – the worst slowdown in more than a quarter of a century. The data was below an official estimate of 4.9 % annual growth and compared with 4.5 % in the last fiscal year. However, the current account deficit narrowed sharply to $ 32.4 billion at 1.7 % of gross domestic product, in 2013/14 from a record high of $ 98.8 billion or 4.7 %, the year before.A sharp fall in gold imports due to restrictions on overseas purchases and muted import of capital goods helped shrink the current account deficit.

 

Online retailer Flipkart has acquired fashion portal Myntra as it prepares to battle with the rapidly expanding India arm of the global e-commerce giant Amazon. The company raised $ 210 million from Russian Investment firm DST Global which has also invested in companies like Facebook, Twitter and Alibaba Group.

 

General Motors will start exporting vehicles from its Talegaon plant near Pune in the second half of 2014. GM was one of the few global carmakers that was using its India plant only for the domestic market.

 

Google has overtaken Apple as the world’s top brand in terms of value, according to global market research agency Millward Brown. Google’s brand value shot up 40 % in a year to $ 158.84 billion. The top 10 of the 100 slots were dominated by US companies.

 

Infosys lost another heavy weight when B G Srinivas, a board member put in his papers. He is the third CEO-hopeful to quit after Chairman N R Narayana Murthy’s return to the company – Ashok Vemuri and V Balakrishnan being the other two.While Vemuri went on to lead IGate, Balakrishnan joined politics.

 

Naresh Goyal – promoted Jet Airways posted biggest quarterly loss – Rs 2153.37 crore – in the three months ended March 31, mainly because it has been offering discounts to passengers to fill planes.

 

William S Pinckney – Chairman and CEO of Amway India was arrested by the Andhra Pradesh Police in connection with a complaint against the direct selling firm. This is the second time that he has been taken into custody. A year, ago the Kerala Police had arrested Pinckney and two company directors on charges of financial irregularities.

 

China has told its state-owned enterprises to sever links with American consulting firms after the United States charged five Chinese military officers wih hacking US companies. China’s action which targets consultancies like McKinsey & Co. and the Boston Consulting Group, sterns from fears that the first are providing trade secrets to the US governments.

 

India has emerged as a country with some of the highest unregistered businesses in the world. Indonesia has the maximum number of shadow businesses, says a study of 68 countries by Imperial College Business School in London.

 

Pfizer has abandoned its attempt to buy AstraZeneca for nearly $ 118 billion after the latter refused an offer of 55 pounds a share.

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CRISIL

Rating

Long term rating = BB-

Rating Explanation

Inadequate degree of safety and high credit risk.

Date

April 09, 2014

 

 

Rating Agency Name

CRISIL

Rating

Short term rating = A4+

Rating Explanation

Minimal degree of safety and very high credit risk.

Date

April 09, 2014

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

INFORMATION PARTED BY [GENERAL DETAILS]

 

Name :

Ms. Priya

Designation :

Export Department

Contact No.:

91-22-241447018/ 24164382

Date :

17.07.2014

 

 

LOCATIONS

 

Registered Office :

323-F, Bhagat Bhuvan, Dr. Ambedkar Road, Matunga (East), Mumbai – 400019, Maharashtra, India

Tel. No.:

91-22-24144701/ 24164382/  24170671/ 72/ 73/ 74

Fax No.:

91-22-24164397

E-Mail :

bdcointimations@gmail.com

cbcpharm@vsnl.com

cbcpharm@eth.net

Website :

http://www.cbcpharma.com

 

 

DIRECTORS

 

AS ON 20.09.2013

 

Name :

Mr. Pranav Hemant Bhagat

Designation :

Director

Address :

323-F, Bhagat Bhuvan, Dr. Ambedkar Road, Matunga (East), Mumbai – 400019, Maharashtra, India

Date of Birth/Age :

10.02.1985

Date of Appointment :

17.05.2004

DIN No.:

00156362

 

 

Name :

Mr. Hemant Chandravadan Bhagat

Designation :

Director

Address :

323-F, Bhagat Bhuvan, Dr. Ambedkar Road, Matunga (East), Mumbai – 400019, Maharashtra, India

Date of Birth/Age :

05.10.1961

Date of Appointment :

10.03.2003

DIN No.:

00233530

 

 

Name :

Mr. Bharatkumar Himmatlal Makati

Designation :

Director

Address :

A-404, Suryakiran Apartment, Sector 5, Ghansoli, Navi Mumbai – 400701, Maharashtra, India

Date of Birth/Age :

04.02.1959

Date of Appointment :

26.12.2012

DIN No.:

05316803

 

 

Name :

Mr. Shreekant Krishna Shetty

Designation :

Director

Address :

62-B, Vishram Tower, 1st Floor, Wagle Estate, Sector 9, Sreenagar, Thane (West), Thane – 400604, Maharashtra, India

Date of Birth/Age :

24.09.1965

Date of Appointment :

26.12.2012

DIN No.:

05317103

 

 

KEY EXECUTIVES

 

Name :

Ms. Priya

Designation :

Export Department

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 20.09.2013

 

Names of Shareholders

 

No. of Shares

 

Bhagat Chandravadan Padmaben

 

40000

Bhagat Chandravadan Mahesh

 

15000

Bhagat Chandravadan Hemant

 

142000

Bhagat Chhotelal Chandravadan

 

25000

Bhagat Hemant Chitra

 

15000

 

 

AS ON 14.11.2013

 

Names of Allottee

 

No. of Shares

 

Bhagat Chandravadan Mahesh

 

88000

 

 

 

Total

 

 

88000

 

 

AS ON 20.09.2013

 

Equity Share Breakup

Percentage of Holding

Category

 

Directors or relatives of directors

100.00

 

 

Total

 

100.00

 

 

 

 

BUSINESS DETAILS

 

Line of Business :

Merchant Exporter of Pharmaceutical Formulations.

 

 

Exports :

 

Products :

Pharmaceutical Formulations

Countries :

·         African Countries

Asian Countries

Middle East

 

 

GENERAL INFORMATION

 

Suppliers :

·         Anuradha Associates

Arch Marketing

All India Drug Supply Company

Amit Enterprises

Canon India Private Limited

Claris Lifesciences Limited

Dev Pharmaceuticals

Purav Poly Pack  

 

 

Customers :

·         Anshu Agency

Mitco Pharmaceuticals

B.M. Pharmaceuticals

Khandelwal Associates

Plus Mark Pharma

Laxmi Health Agencies

Salwan Distributors

Oxygen Pharma 

 

 

No. of Employees :

75 (Approximately)

 

 

Bankers :

·         Bank of Baroda

Chandavarkar Road Branch, 309, Chandavarkar Road, Matunga (C. Rly.), Mumbai - 400019, Maharashtra, India

 

·         HDFC Bank Limited

Kotak Mahindra Bank Limited

Standard Chartered Bank

Union Bank of India

 

 

Facilities :

 

SECURED LOANS

31.03.2013

(Rs. In Millions)

31.03.2012

(Rs. In Millions)

SHORT TERM BORROWINGS

 

 

Loans Repayable on Demand

 

 

From Banks

Bank of Baroda

[Secured against Ray Road Godown and Hypothecation against stock and debtors]

30.409

30.094

Bank of Baroda

[Secured against Bank FD]

16.791

15.589

Local L.C. Liability

BDR Pharmaceuticals LC

2.178

0.000

Car Loan from Bank secured against Car

8.650

11.083

 

 

 

Total

 

58.028

56.766

 

 

 

Banking Relations :

--

 

 

Financial Institution :

Bajaj Finance Limited

 

 

Auditors :

 

Name :

Bharat Desai and Company

Chartered Accountants

Address :

111, Mahatma Gandhi Road, Fort, Mumbai – 400001, Maharashtra, India

Income-tax PAN of auditor or auditor's firm :

AAEPB2439E

 

 

CAPITAL STRUCTURE

 

AFTER 20.09.2013

 

Authorised Capital : Rs. 5.000 Millions

 

Issued, Subscribed & Paid-up Capital : Rs. 4.180 Millions

 

 

AS ON 31.03.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

250,000

Equity Shares

Rs. 10/- each

Rs. 2.500 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

250,000

Equity Shares

Rs. 10/- each

Rs. 2.500 Millions

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2013

31.03.2012

31.03.2011

I.        EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

2.500

2.500

2.500

(b) Reserves & Surplus

31.363

28.996

24.839

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

33.863

31.496

27.339

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

0.000

0.000

0.000

(b) Deferred tax liabilities (Net)

0.000

0.000

0.129

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

0.000

0.000

0.129

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

114.344

106.759

89.772

(b) Trade payables

61.416

62.083

26.950

(c) Other current liabilities

26.511

24.031

20.906

(d) Short-term provisions

0.000

0.000

0.000

Total Current Liabilities (4)

202.271

192.873

137.628

 

 

 

 

TOTAL

236.134

224.369

165.096

 

 

 

 

II.      ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

10.748

11.445

11.149

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

0.000

0.050

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

1.204

2.128

0.000

(d)  Long-term Loan and Advances

0.000

0.000

0.000

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

11.952

13.623

11.149

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

103.412

76.122

65.155

(c) Trade receivables

82.396

82.410

40.529

(d) Cash and cash equivalents

33.137

32.352

31.927

(e) Short-term loans and advances

4.056

19.036

16.407

(f) Other current assets

1.181

0.826

(0.071)

Total Current Assets

224.182

210.746

153.947

 

 

 

 

TOTAL

236.134

224.369

165.096

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2013

31.03.2012

31.03.2011

 

SALES

 

 

 

 

 

Revenue from Operations

201.850

170.570

 

 

Other Income

 

1.939

3.210

 

 

TOTAL                                     (A)

NA

203.789

173.780

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Purchases of Stock-in-Trade

137.057

104.472

 

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

 

(10.967)

(18.385)

 

 

Employees benefits expense

 

33.983

55.397

 

 

Other expenses

 

28.264

33.918

 

 

TOTAL                                     (B)

NA

188.337

175.402

 

 

 

 

 

Less

PROFIT/ (LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

[Including Financial and Depreciation Expenses]

15.452

(1.622)

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

 

12.014

8.637

 

 

 

 

 

 

PROFIT/ (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                               (E)

 

3.438

(10.259)

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

 

1.670

1.948

 

 

 

 

 

 

PROFIT/ (LOSS) BEFORE TAX (E-F)                  (G)

NA

1.768

(12.207)

 

 

 

 

 

Less

TAX                                                                  (H)

NA

(2.259)

(3.283)

 

 

 

 

 

 

PROFIT/ (LOSS) AFTER TAX (G-H)                   (I)

2.367

4.027

(8.924)

 

 

 

 

 

 

Earnings/ (Loss) Per Share (Rs.)

9.47

16.11

(35.70)

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2013

31.03.2012

31.03.2011

PAT / Total Income

(%)

NA

1.98

(5.14)

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

NA

0.88

(7.16)

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

NA

0.80

(7.39)

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

NA

0.06

(0.45)

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

3.38

3.39

3.28

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.11

1.09

1.12

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Share Capital

2.500

2.500

2.500

Reserves & Surplus

24.839

28.996

31.363

Net worth

27.339

31.496

33.863

 

 

 

 

long-term borrowings

0.000

0.000

0.000

Short term borrowings

89.772

106.759

114.344

Total borrowings

89.772

106.759

114.344

Debt/Equity ratio

3.284

3.390

3.377

 

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

 

Sr. No.

Check List by Info Agents

Available in Report

(Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last two years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

No

17]

Major suppliers

Yes

18]

Major customers

Yes

19]

Payments terms

No

20]

Export / Import details (if applicable)

Yes

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

 

CURRENT MATURITIES OF LONG TERM DEBT: NOT AVAILABLE

 

 

INDEX OF CHARGES

 

S.NO.

CHARGE ID

DATE OF CHARGE CREATION/MODIFICATION

CHARGE AMOUNT SECURED

CHARGE HOLDER

ADDRESS

SERVICE REQUEST NUMBER (SRN)

1

10046547

27/04/2013 *

110,000,000.00

BANK OF BARODA

CHANDAVARKAR ROAD BRANCH, 309, CHANDAVARKAR ROAD, MATUNGA (C. RLY.), MUMBAI, MAHARASHTRA - 400019, INDIA

B74200460

2

10013447

03/08/2006

6,000,000.00

BANK OF BARODA

CHANDAVARKAR ROAD BRANCH, 309, CHANDAVARKAR ROAD, MATUNGA (C. RLY.), MUMBAI, MAHARASHTRA - 400019, INDIA

A03211216

3

90146821

27/04/2013 *

110,000,000.00

BANK OF BARODA

CHANDAVARKAR ROAD BRANCH, 309, CHANDAVARKAR ROAD, MATUNGA (C. RLY.), MUMBAI, MAHARASHTRA - 400019, INDIA

B74201096

4

90148998

04/01/2005 *

21,000,000.00

BANK OF BARODA

CHANDAVARKAR ROAD BRANCH, 309, CHANDAVARKAR ROAD, MATUNGA (C. RLY.), MUMBAI, MAHARASHTRA - 400019, INDIA

-

5

90148388

15/09/2003

1,000,000.00

BANK OF BARODA

CHANDAVARKAR ROAD BRANCH, 309, CHANDAVARKAR ROAD, MATUNGA (C. RLY.), MUMBAI, MAHARASHTRA - 400019, INDIA

-

6

90149166

15/09/2003

10,000,000.00

BANK OF BARODA

CHANDAVARKAR ROAD BRANCH, 309, CHANDAVARKAR ROAD, MATUNGA (C. RLY.), MUMBAI, MAHARASHTRA - 400019, INDIA

-

 

* Date of charge modification

 

 

UNSECURED LOANS

 

UNSECURED LOANS

31.03.2013

(Rs. In Millions)

31.03.2012

(Rs. In Millions)

SHORT TERM BORROWINGS

 

 

From Directors

14.493

19.066

From Others

Bajaj Finance Limited

1.220

2.009

From Related Parties

40.603

28.918

 

 

 

Total

 

56.316

49.993

 

 

REVIEW OF OPERATION

 

During the year, the Company has earned profit of Rs. 2.367 Millions as against Rs.4.027 Millions during the previous financial year. The Directors are continuously looking for avenues for future growth of the Company in the industry.

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 60.14

UK Pound

1

Rs. 103.00

Euro

1

Rs. 81.33

 

 

INFORMATION DETAILS

 

Information Gathered by :

PDT

 

 

Analysis Done by :

KAR

 

 

Report Prepared by :

BVA

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

4

PAID-UP CAPITAL

1~10

3

OPERATING SCALE

1~10

4

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

4

--PROFITABILIRY

1~10

3

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

3

--CREDIT LINES

1~10

3

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTERS 

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

30

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.